Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000545897 | SCV000643876 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-05-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620930 | SCV000736681 | uncertain significance | Cardiovascular phenotype | 2019-02-05 | criteria provided, single submitter | clinical testing | The p.L21086F variant (also known as c.63256C>T), located in coding exon 162 of the TTN gene, results from a C to T substitution at nucleotide position 63256, and is located in the A-band region of the N2-B isoform of the titin protein. The leucine at codon 21086 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769889 | SCV000901315 | uncertain significance | Cardiomyopathy | 2017-09-07 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001778999 | SCV002015081 | uncertain significance | not specified | 2021-10-02 | criteria provided, single submitter | clinical testing |